BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
30649166
Number of visits today
150
Number of downloads
13089341
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Pleyer U, Algharably EA, Feist E, Kreutz R. Small molecules as therapy for uveitis: a selected perspective of new and developing agents. Expert Opin Pharmacother 2017;18:1311-23. [PMID: 28750572 DOI: 10.1080/14656566.2017.1361408] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Gueudry J, Touhami S, Quartier P, Bodaghi B. Therapeutic advances in juvenile idiopathic arthritis - associated uveitis. Current Opinion in Ophthalmology 2019;30:179-86. [DOI: 10.1097/icu.0000000000000559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
2 Tugal-Tutkun I, Çakar Özdal P. Behçet's disease uveitis: is there a need for new emerging drugs? Expert Opin Emerg Drugs 2020;25:531-47. [PMID: 33147420 DOI: 10.1080/14728214.2020.1847271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Agarwal A, Rübsam A, zur Bonsen L, Pichi F, Neri P, Pleyer U. A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments. JCM 2022;11:2525. [DOI: 10.3390/jcm11092525] [Reference Citation Analysis]
4 Fragoulis GE, McInnes IB, Siebert S. JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis. Rheumatology (Oxford) 2019;58:i43-54. [PMID: 30806709 DOI: 10.1093/rheumatology/key276] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 46.0] [Reference Citation Analysis]
5 Gueudry J, Leclercq M, Saadoun D, Bodaghi B. Old and New Challenges in Uveitis Associated with Behçet's Disease. J Clin Med 2021;10:2318. [PMID: 34073249 DOI: 10.3390/jcm10112318] [Reference Citation Analysis]
6 Campos PM, Petrilli R, Lopez RFV. The prominence of the dosage form design to treat ocular diseases. Int J Pharm 2020;586:119577. [PMID: 32622806 DOI: 10.1016/j.ijpharm.2020.119577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Pohlmann D, Rademacher J, Pleyer U. HLA-B27 assoziierte anteriore Uveitis: Herausforderung für eine interdisziplinäre Zusammenarbeit. Aktuelle Rheumatologie 2021;46:524-31. [DOI: 10.1055/a-1662-4086] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345